Published in J Infect Dis on November 01, 2009
Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis. PLoS Negl Trop Dis (2015) 1.51
Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol (2011) 1.16
New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes Infect (2011) 1.14
Anthrax prophylaxis: recent advances and future directions. Front Microbiol (2015) 0.92
Raxibacumab: potential role in the treatment of inhalational anthrax. Infect Drug Resist (2014) 0.85
Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. Shock (2011) 0.83
Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat. Biomed Res Int (2014) 0.75
Surviving Between Hosts: Sporulation and Transmission. Microbiol Spectr (2016) 0.75
Crossing of the epithelial barriers by Bacillus anthracis: the Known and the Unknown. Front Microbiol (2015) 0.75
Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One (2007) 4.95
Human FcγRIIA induces anaphylactic and allergic reactions. Blood (2011) 1.86
Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog (2007) 1.70
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol (2005) 1.61
Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol (2005) 1.59
Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood (2008) 1.58
Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun (2006) 1.53
The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med (2010) 1.51
Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin. Proc Natl Acad Sci U S A (2004) 1.51
Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood (2005) 1.39
Identification of the Bacillus anthracis (gamma) phage receptor. J Bacteriol (2005) 1.17
Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol (2011) 1.16
Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol (2007) 1.14
Differential protein modulation in midguts of Aedes aegypti infected with chikungunya and dengue 2 viruses. PLoS One (2010) 1.14
Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and saliva-immunized mice. PLoS One (2012) 1.13
cAMP signaling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerization. Cell Host Microbe (2011) 1.06
Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability. Am J Pathol (2007) 1.06
Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. PLoS Pathog (2009) 1.04
Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. J Immunol (2011) 1.03
In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J Immunol (2005) 1.02
Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol (2006) 1.01
Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia. Microbes Infect (2010) 1.00
Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect (2008) 0.99
Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog (2012) 0.98
High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J Immunol (2004) 0.98
Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathog (2007) 0.96
Progenitor cell isolation from muscle-derived cells based on adhesion properties. J Histochem Cytochem (2007) 0.95
Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia. J Immunol (2009) 0.94
Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J Infect Dis (2011) 0.94
Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs. Am J Pathol (2011) 0.93
Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice. Infect Immun (2007) 0.92
Roles of cell adhesion and cytoskeleton activity in Entamoeba histolytica pathogenesis: a delicate balance. Infect Immun (2005) 0.89
The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance. Mol Microbiol (2013) 0.88
Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice. J Infect Dis (2011) 0.88
In vivo germination of Bacillus anthracis spores during murine cutaneous infection. J Infect Dis (2012) 0.87
Bacillus anthracis: balancing innocent research with dual-use potential. Int J Med Microbiol (2008) 0.87
Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun (2008) 0.86
Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope. Infect Immun (2003) 0.85
Localization of the Clostridium difficile cysteine protease Cwp84 and insights into its maturation process. J Bacteriol (2011) 0.83
Human herpesvirus 8 genotype E in patients with Kaposi sarcoma, Peru. Emerg Infect Dis (2010) 0.83
Clostridium difficile surface proteins are anchored to the cell wall using CWB2 motifs that recognise the anionic polymer PSII. Mol Microbiol (2015) 0.81
Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host. Biochimie (2010) 0.80
Femtomolar detection of the anthrax edema factor in human and animal plasma. Anal Chem (2009) 0.80
Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection. Vaccine (2002) 0.80
Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation. Biochem Pharmacol (2009) 0.77
Sensitive detection of Bacillus anthracis spores by immunocapture and liquid chromatography-tandem mass spectrometry. Anal Chem (2011) 0.77
Identification and validation of specific markers of Bacillus anthracis spores by proteomics and genomics approaches. Mol Cell Proteomics (2013) 0.75
Corrigendum: In vivo dynamics of active edema and lethal factors during anthrax. Sci Rep (2017) 0.75
[Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape?]. Bull Acad Natl Med (2006) 0.75
Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line. J Bone Miner Res (2004) 0.75
Multiparametric functional nuclear magnetic resonance imaging shows alterations associated with plasmid electrotransfer in mouse skeletal muscle. J Gene Med (2012) 0.75